Ursodeoxycholic acid promotes intestinal adaptation in a cat model of short bowel syndrome

Fundamental and Clinical Pharmacology

Volumn 25, Issue 6, 2011, Pages 734-742

  Kouti, Vasileia ^a   Papazoglou, Lysimachos ^a   Flaskos, John ^a   Angelopoulou, Katerina ^a   Karkavelas, Georgios ^a   Rallis, Timoleon ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Intestinal adaptation; Jejunoileal resection; Short bowel syndrome; Sucrase; Ursodeoxycholic acid

Indexed keywords

ALKALINE PHOSPHATASE; DNA; PROTEIN; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEFECATION; DIARRHEA; EXPERIMENTAL CAT; HISTOPATHOLOGY; HYPERPLASIA; INTESTINE RESECTION; INTESTINE VILLUS; JEJUNUM MUCOSA; MICROSCOPY; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; SHORT BOWEL SYNDROME;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CATS; CHOLAGOGUES AND CHOLERETICS; DIARRHEA; DISEASE MODELS, ANIMAL; DNA; HYPERPLASIA; ILEUM; INTESTINAL MUCOSA; JEJUNUM; SHORT BOWEL SYNDROME; SUCRASE; URSODEOXYCHOLIC ACID;

EID: 80054911243     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00901.x     Document Type: Article

References (37)

1. Vanderhoof J.A., Langnas A.N. Short-bowel syndrome in children and adults. Gastroenterology (1997) 113 1767-1778.
2. Drozdowski L., Thomson A.B. Intestinal mucosal adaptation. World J. Gastroenterol. (2006) 12 4614-4627.
3. Tilson M.D. Pathophysiology and treatment of short bowel syndrome. Surg. Clin. North Am. (1980) 60 1273-1284.
4. Williamson R.C.N., Bauer F.L.R., Ross J.S., Malt R.A. Contributions of bile and of pancreatic juice to cell proliferation in ileal mucosa. Surgery (1978) 83 570-576.
5. Roy C.C., Laurendeau G., Doyon G., Chartrand L., Rivest M.R. The effect of bile and of sodium taurocholate on the epithelial cell dynamics of the rat small intestine. Proc. Soc. Exp. Biol. Med. (1975) 149 1000-1004.
6. Washizu T., Tomoda I., Kaneko J. Serum bile acid composition of the dog, cow, horse and human. J. Vet. Med. Sci. (1991) 53 81-86.
7. Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. (2006) 3 318-328.
8. Webster C.R.L. Ursodeoxycholic acid therapy, in: Bonagura J.D., Twedt D.C. (Eds), Kirk's current veterinary therapy XIV, V, Saunders, Philadelphia, USA, 2008, pp. 563-565.
9. Okolicsanyi L., Lirussi F., Strazzabosco M. et al. The effect of drugs on bile flow and composition. An overview. Drugs (1986) 31 430-448.
10. Ward A., Brodgen R.N., Heel R.C., Speight T.M., Avery G.S. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy. Drugs (1984) 27 95-131.
11. Imamura M., Yamauchi H. Effects of massive small bowel resection on metabolism of bile acids and vitamin D3 and gastrin release in dogs. Tohoku J. Exp. Med. (1992) 168 515-528.
12. Kararli T.T. Comparison of the gastrointestinal anatomy, physiology and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. (1995) 16 351-380.
13. +/peptide transporter PepT1 in human intestine: up-regulated expression in the colonic mucosa of patients with short bowel syndrome. Am. J. Clin. Nutr. (2002) 75 922-930.
14. O'Brien S.J., Johnson W., Driscoll C., Pontius J., Pecon-Slattery J., Menotti-Raymond M. State of cat genomics. Trends Genet. (2008) 24 268-279.
15. Nicholson B.T., Center S.A., Randolph J.F. et al. Effects of oral ursodeoxycholic acid in healthy cats on clinicopathological parameters, serum bile acids and light microscopic and ultrastructural features of the liver. Res. Vet. Sci. (1996) 61 258-262.
16. Podda M., Ghezzi C., Battezzati P.M. et al. Ursodeoxycholic acid for chronic liver diseases. J. Clin. Gastroenterol. (1988) 10 S25-S31.
17. Poupon R.E., Balkau B., Eschwége E., Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N. Engl. J. Med. (1991) 324 1548-1554.
18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. (1951) 193 265-275.
19. Dahlqvist A. Assay of intestinal disaccharidases. Anal. Biochem. (1968) 22 99-107.
20. Kelly M.H., Hamilton J.R. A micro-technique for the assay of intestinal alkaline phosphatase. Results in normal children and in children with celiac disease. Clin. Biochem. (1970) 3 33-43.
21. Sukhotnik I., Yakirevich E., Coran A.G. et al. Lipopolysaccharide endotoxemia reduces cell proliferation and decreases enterocyte apoptosis during intestinal adaptation in a rat model of short bowel syndrome. Pediatr. Surg. Int. (2002) 18 615-619.
22. Xin Z., Yuan Xin L., Ning L., Jie S.L. Effect of bowel rehabilitative therapy on structural adaptation of remnant small intestine: animal experiment. World J. Gastroenterol. (2001) 7 66-73.
23. Lauronen J., Pakarinen M.P., Kuusanmäki P., Savilahti E., Vento P. Intestinal adaptation after massive proximal small-bowel resection in the pig. Scand. J. Gastroenterol. (1998) 33 152-158.
24. Kuehl R. Designs of experiments: statistical principles of research design and analysis. Duxbury Thomson Learning, Pacific Grove, USA, 2000.
25. Girden E. ANOVA: repeated measures. Sage Publications, Newbury Park, USA, 1992.
26. Toothaker L. Multiple comparison procedures. Sage Publications, Newbury Park, USA, 1993.
27. Johnson W.F., DiPalma C.R., Ziegler T.R., Scully S., Farrell L. Keratinocyte growth factor enhances early gut adaptation in a rat model of short bowel syndrome. Vet. Surg. (2000) 29 17-27.
28. Porus R.L. Epithelial hyperplasia following massive small bowel resection in man. Gastroenterology (1965) 48 753-757.
29. Weser E., Hernandez M.H. Studies of small bowel adaptation after intestinal resection in the rat. Gastroenterology (1971) 60 69-75.
30. McCarthy D.M., Kim Y.S. Changes in sucrase, enterokinase, and peptide hydrolase after intestinal resection. The association of cellular hyperplasia and adaptation. J. Clin. Invest. (1973) 52 942-951.
31. Buts J.P., De Keyser N., Dive C. Cellular adaptation of the rat small intestine after proximal enterectomy: changes in microvillus enzymes and in the secretory component of immunoglobulins. Pediatr. Res. (1987) 22 29-33.
32. Gillingham M.B., Dahly E.M., Murali S.G., Ney D.M. IGF-I treatment facilitates transition from parenteral to enteral nutrition in rats with short bowel syndrome. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2003) 284 R363-R371.
33. Thomson A.B., Wild G. Adaptation of intestinal nutrient transport in health and disease. Part I. Dig. Dis. Sci. (1997) 42 453-469.
34. Narisawa S., Huang L., Iwasaki A., Hasegawa H., Alpers D.H., Millan J.L. Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol. Cell. Biol. (2003) 23 7525-7530.
35. Hansen G.H., Niels-Christiansen L.-L., Immerdal L., Nystrom B.T., Danielsen E.M. Intestinal alkaline phosphatase: selective endocytosis from the enterocyte brush border during fat absorption. Am. J. Physiol. Gastrointest. Liver Physiol. (2007) 293 G1325-G1332.
36. von Bergmann K., Epple-Gutsfeld M., Leiss O. Differences in the effects of chenodeoxycholic acid and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology (1984) 87 136-143.
37. Frenkiel P.G., Lee D.W.T., Cohen H. et al. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid. Am. J. Clin. Nutr. (1986) 43 239-250.